St Jude Medical's new manufacturing facility in Penang Island, Malaysia, has received European CE mark approval for production of pacemakers and leads.
The manufacturing facility will initially produce products for the St Jude‘s Cardiac Rhythm Management Division.
The first products have already been shipped to the company’s distribution center in Veddesta, Sweden.
In addition to pacemakers and leads, St Jude Medical plans to expand production to include additional products, such as implantable cardioverter defibrillators (ICDs).
St Jude chairman, president and CEO Daniel Starks said the new manufacturing facility in Malaysia provides St Jude Medical with the opportunity to leverage our continued growth in international markets.
"By expanding our global footprint, we have created a sustainable competitive advantage that will help us to provide our lifesaving technologies to even more patients and customers," Starks said.